Mortality in Advanced Chronic Obstructive Pulmonary Disease and Heart Failure Following Cardiopulmonary Rehabilitation

Abstract

Cardiopulmonary rehabilitation (CR) improves physical function and quality of life (QoL) in chronic obstructive pulmonary disease (COPD) and heart failure (HF), but it is unknown if CR improves outcomes in very severe disease. This study’s purpose was to describe functional capacity (6-min walk distance [6MWD], steps/day), symptoms (dyspnea, depression), QoL (Short-Form Health Survey–Veterans [SF-36 V]) and cardiopulmonary function (N-terminal pro-brain natriuretic peptide [NT-proBNP], forced expiratory volume in 1 s [FEV₁]), and derive predictors of mortality among patients with severe COPD and HF who participated in CR.

Methods and Results:

In this secondary analysis of a randomized controlled trial comparing two CR methods in severe COPD and HF, 90 (COPD = 63, HF = 27) male veterans, mean age 66 ± 9.24 years, 79% Caucasian, and body mass index 31 kg/m², were followed for 12 months after CR. The COPD group had greater functional decline than the HF group (6MWD, p = .006). Dyspnea was lower (p = .001) and QoL higher (p = .006) in the HF group. Mean NT-proBNP was higher in the HF group at all time points. FEV₁ improved over 12 months in both groups (p = .01). Mortality was 8.9%, 16.7%, and 37.8% at 12, 24, and 60 months, respectively. One-year predictors of mortality were baseline total steps (<3,000/day), 6MWD (<229 meters), and NT-proBNP level (>2,000 mg/pg).

Conclusions:

In very severe COPD and HF, risks of mortality over 12 months can predict patients unlikely to benefit from CR and should be considered at initial referral.

Keywords

mortality COPD heart failure cardiac rehabilitation pulmonary rehabilitation

Get full access to this article

View all access options for this article.

References

American Heart Association. (2016). What is heart failure? Retrieved from http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/About-Heart-Failure_UCM_002044_Article.jsp#.V0VC6fkrJpg

American Lung Association. (2016). Chronic obstructive pulmonary disease (COPD). Retrieved from http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/

Apostolovic

Jankovic-Tomasevic

Salinger-Martinovic

Djordjevic-Radojkovic

Stanojevic

Pavlovic

… Düngen

H. D.

(2011). Frequency and significance of unrecognized chronic obstructive pulmonary disease in elderly patients with stable heart failure. Aging Clinical and Experimental Research, 23, 337–342. doi:10.3275/7291

Baggish

A. L.

van Kimmenade

R. R.

Januzzi

J. L.

Jr (2008). Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. American Journal of Cardiology, 101, 49–55. doi:10.1016/j.amjcard.2007.11.020

Blumenthal

J. A.

Smith

P. J.

Durheim

Mabe

Emery

C. F.

Martinu

… Palmer

(2016). Biobehavioral prognostic factors in chronic obstructive pulmonary disease: Results from the INSPIRE-II trial. Psychosomatic Medicine, 78, 153–162. doi:10.1097/PSY.0000000000000260

Boueri

F. M.

Bucher-Bartelson

B. L.

Glenn

K. A.

Make

B. J.

(2001). Quality of life measured with a generic instrument (short form-36) improves following pulmonary rehabilitation in patients with COPD. Chest, 119, 77–84.

Carson

P. E.

Anand

I. S.

Win

Rector

Haass

Lopez-Sendon

… Massie

(2015). The hospitalization burden and post-hospitalization mortality risk in heart failure with preserved ejection fraction: Results from the I-PRESERVE trial (Irbesartan in heart failure and preserved ejection fraction). Journal of the American College of Cardiology. Heart Failure, 3, 429–441. doi:10.1016/j.jchf.2014.12.017

Cavanaugh

J. T.

Coleman

K. L.

Gaines

J. M.

Laing

Morey

M. C.

(2007). Using step activity monitoring to characterize ambulatory activity in community-dwelling older adults. Journal of the American Geriatrics Society, 55, 120–124.

Cavill

Kahlmeier

Racioppi

(Eds.). (2006). Physical activity and health in Europe: Evidence for action. Copenhagen, Denmark: World Health Organization. Retrieved from http://www.euro.who.int/document/e89490.pdf

10.

Chamberlain

A. M.

McNallan

S. M.

Dunlay

S. M.

Spertus

J. A.

Redfield

M. M.

Moser

D. K.

… Roger

V. L.

(2013). Physical health status measures predict all-cause mortality in patients with heart failure. Circulation: Heart Failure, 6, 669–675. doi:10.1161/CIRCHEARTFAILURE.112.000291

11.

Charlson

Pompei

Ales

MacKenzie

(1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373–383.

12.

Dajczman

Wardini

Kasymjanova

Prefontaine

Baltzan

M. A.

Wolkove

(2015). Six minute walk distance is a predictor of survival in patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation. Canadian Respiratory Journal, 22, 225–229.

13.

Duncan

(2016). Chronic obstructive pulmonary disease: An overview. British Journal of Nursing (Mark Allen Publishing), 25, 360–366. doi:10.12968/bjon.2016.25.7.360

14.

Durheim

M. T.

Smith

P. J.

Babyak

M. A.

Mabe

S. K.

Martinu

Welty-Wolf

K. E.

… Blumenthal

J. A.

(2015). Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of global initiative for chronic obstructive lung disease 2011 Group. Annals of the American Thoracic Society, 12, 349–356. doi:10.1513/AnnalsATS.201408-365OC

15.

Dwyer

Pezic

Sun

Cochrane

Venn

Srikanth

… Ponsonby

A. L.

(2015). Objectively measured daily steps and subsequent long term all-cause mortality: The tasped prospective cohort study. PLOS One, 10, e0141274. doi:10.1371/journal.pone.0141274

16.

Fleg

J. L.

Cooper

L. S.

Borlaug

B. A.

Haykowsky

M. J.

Kraus

W. E.

Levine

B. D.

… Kitzman

D. W.

(2015). Exercise training as therapy for heart failure: Current status and future directions. Circulation: Heart Failure, 8, 209–220. doi:10.1161/CIRCHEARTFAILURE.113.001420

17.

Fonarow

G. C.

(2012). Clinical risk prediction tools in patients hospitalized with heart failure. Reviews in Cardiovascular Medicine, 13, e14–e23.

18.

Gaggin

H. K.

Januzzi

J. L.

Jr (2013). Biomarkers and diagnostics in heart failure. Biochimica et Biophysica Acta, 1832, 2442–2450. doi:10.1016/j.bbadis.2012.12.014

19.

Gavazzi

De Maria

Manzoli

Bocconcelli

Di Leonardo

Frigerio

… Deales

(2015). Palliative needs for heart failure or chronic obstructive pulmonary disease: Results of a multicenter observational registry. International Journal of Cardiology, 184, 552–558. doi:10.1016/j.ijcard.2015.03.056

20.

Guell

M. R.

Cejudo

Ortega

Puy

M. C.

Rodriguez-Trigo

Pijoan

J. I.

… Galdiz

J. B.

(2017). Benefits of long-term pulmonary rehabilitation maintenance program in patients with severe chronic obstructive pulmonary disease. Three-year follow-up. American Journal of Respiratory and Critical Care Medicine, 195, 622–629. doi:10.1164/rccm.201603-0602OC

21.

Haeuber

Shaughnessy

Forrester

L. W.

Coleman

K. L.

Macko

R. F.

(2004). Accelerometer monitoring of home-and community-based ambulatory activity after stroke. Archives of Physical Medicine and Rehabilitation, 85, 1997–2001.

22.

Janssen

D. J.

Spruit

M. A.

Uszko-Lencer

N. H.

Schols

J. M.

Wouters

E. F.

(2011). Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. Journal of Palliative Medicine, 14, 735–743. doi:10.1089/jpm.2010.0479

23.

Jelic

Le Jemtel

T. H.

(2006). Diagnostic usefulness of B-type natriuretic peptide and functional consequences of muscle alterations in COPD and chronic heart failure. Chest, 130, 1220–1230.

24.

Jolly

Taylor

R. S.

Lip

G. Y.

Davies

Davis

Mant

… Stevens

(2009). A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: The Birmingham Rehabilitation Uptake Maximisation Study for patients with Congestive Heart Failure (BRUM-CHF) study. European Journal of Heart Failure, 11, 205–213. doi:10.1093/eurjhf/hfn029

25.

Kazis

L. E.

Miller

D. R.

Clark

Skinner

Lee

Rogers

Linzer

(1998). Health-related quality of life in patients served by the department of veterans affairs: Results from the veterans health study. Archives of Internal Medicine, 158, 626–632.

26.

Khazanie

Heizer

G. M.

Hasselblad

Armstrong

P. W.

Califf

R. M.

Ezekowitz

… Starling

(2015). Predictors of clinical outcomes in acute decompensated heart failure: Acute study of clinical effectiveness of nesiritide in decompensated heart failure outcome models. American Heart Journal, 170, 290–297. doi:10.1016/j.ahj.2015.04.006

27.

L. S.

Caughey

Johnston

(2014). Comorbidity associated with referral to pulmonary rehabilitation in people hospitalized with chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation and Prevention, 34, 430–436. doi:10.1097/HCR

28.

Louvaris

Vogiatzis

(2015). Physiological basis of cardiopulmonary rehabilitation in patients with lung or heart disease. Breathe (Sheffield, England), 11, 120–127. doi:10.1183/20734735.021114

29.

Man

W. D.

Chowdhury

Taylor

R. S.

Evans

R. A.

Doherty

Singh

S. J.

… Cowie

M. R.

(2016). Building consensus for provision of breathlessness rehabilitation for patients with chronic obstructive pulmonary disease and chronic heart failure. Chronic Respiratory Disease, 13, 229–239. doi:10.1177/1479972316642363

30.

Martinez

F. J.

Foster

Curtis

J. L.

Criner

Weinmann

Fishman

… Wise

(2006). Predictors of mortality in patients with emphysema and severe airflow obstruction. American Journal of Respiratory and Critical Care Medicine, 173, 1326–1334. doi:10.1164/rccm.200510-1677OC

31.

McCarthy

Casey

Devane

Murphy

Lacasse

(2015). Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 23, CD003793. doi:10.1002/14651858.CD003793.pub3

32.

Mentz

R. J.

Schmidt

P. H.

Kwasny

M. J.

Ambrosy

A. P.

O’Connor

C. M.

Konstam

M. A.

… Gheorghiade

(2012). The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: An analysis of the EVEREST trial. Journal of Cardiac Failure, 18, 515–523. doi:10.1016/j.cardfail.2012.04.010

33.

Miller

Crapo

Hankinson

Brusasco

Burgos

Casaburi

… Wanger

(2005). General considerations for lung function testing. European Respiratory Journal, 26, 153–161.

34.

Nguyen

H. Q.

Burr

R. L.

Gill

D. P.

Coleman

(2011). Validation of the step watch device for measurement of free-living ambulatory activity in patients with chronic obstructive pulmonary disease. Journal of Nursing Measurement, 19, 76–90.

35.

Nunez

Bayes-Genis

Fonarow

G. C.

Minana

Bodi

… Sanchis

(2016). Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure. European Heart Journal. Acute Cardiovascular Care, 6, 685–696. doi:10.1177/2048872616649757

36.

O’Connor

C. M.

Whellan

D. J.

Wojdyla

Leifer

Clare

R. M.

Ellis

S. J.

… Lee

K. L.

(2012). Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: The HF-ACTION predictive risk score model. Circulation: Heart Failure, 5, 63–71. doi:10.1161/CIRCHEARTFAILURE.111.963462

37.

Osthoff

Jenkins

Leuppi

(2013). Chronic obstructive pulmonary disease—A treatable disease. Swiss Medical Weekly, 143, w13777. doi:10.4414/smw.2013.13777

38.

Padeletti

Relic

LeJemtel

T. H.

(2008). Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. International Journal of Cardiology, 125, 209–215. doi:10.1016/j.ijcard.2007.12.001

39.

Pelle

A. J.

Gidron

Y. Y.

Szabo

B. M.

Denollet

(2008). Psychological predictors of prognosis in chronic heart failure. Journal of Cardiac Failure, 14, 341–350. doi:10.1016/j.cardfail.2008.01.004

40.

Polkey

M. I.

Spruit

M. A.

Edwards

L. D.

Watkins

M. L.

Pinto-Plata

Vestbo

… Coxson

H. O.

(2013). Six-minute-walk test in chronic obstructive pulmonary disease: Minimal clinically important difference for death or hospitalization. American Journal of Respiratory and Critical Care Medicine, 187, 382–386. doi:10.1164/rccm.201209-1596OC

41.

Puhan

M. A.

Scharplatz

Troosters

Steurer

(2005). Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality—A systematic review. Respiratory Research, 6, 54.

42.

Richter

Koller

Hohensinner

P. J.

Zorn

Brekalo

Berger

… Niessner

(2013). A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure. International Journal of Cardiology, 168, 1251–1257. doi:10.1016/j.ijcard.2012.11.052

43.

Rutten

F. H.

Cramer

M. J.

Zuithoff

N. P.

Lammers

J. W.

Verweij

Grobbee

D. E.

Hoes

A. W.

(2007). Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. European Journal of Heart Failure, 9, 651–659.

44.

Sagar

V. A.

Davies

E. J.

Briscoe

Coats

A. J.

Dalal

H. M.

Lough

… Taylor

R. S.

(2015). Exercise-based rehabilitation for heart failure: Systematic review and meta-analysis. Open Heart, 2, e000163. doi:10.1136/openhrt-2014-000163

45.

Singh

J. A.

(2016). Utilization due to chronic obstructive pulmonary disease and its predictors: A study using the U.S. National Emergency Department Sample (NEDS). Respiratory Research, 17, 1. doi:10.1186/s12931-015-0319-y

46.

Sprenkle

M. D.

Niewoehner

D. E.

Nelson

D. B.

Nichol

K. L.

(2004). The veterans short form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD. Chest, 126, 81–89. doi:10.1378/chest.126.1.81

47.

Steele

B. G.

Belza

Cain

K. C.

Coppersmith

Lakshminarayan

Howard

Haselkorn

J. K.

(2008). A randomized clinical trial of an activity and exercise adherence intervention in chronic pulmonary disease. Archives of Physical Medicine and Rehabilitation, 89, 404–412. doi:10.1016/j.apmr.2007.11.003

48.

Steele

B. G.

Dougherty

C. M.

Burr

R. L.

Gylys-Colwell

Hunziker

(2017). A feasibility trial of two rehabilitation models in severe cardiopulmonary illness. Rehabilitation Nursing. Advance online publication. doi:10.1097/rnj.0000000000000115

49.

Theander

Hasselgren

Luhr

Eckerblad

Unosson

Karlsson

(2014). Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health care. International Journal of Chronic Obstructive Pulmonary Disease, 9, 785–794. doi:10.2147/COPD.S62563

50.

Troosters

Bourbeau

Maltais

Leidy

Erzen

De Sousa

… Hamilton

(2016). Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design. BMJ Open, 6, e010106. doi:10.1136/bmjopen-2015-010106

51.

Troosters

VanRemoortel

(2009). Pulmonary rehabilitation and cardiovascular disease. Seminars in Respiratory and Critical Care Medicine, 30, 675–683.

52.

Tzanis

Philippou

Karatzanos

Dimopoulos

Kaldara

Nana

… Nanas

(2016). Effects of high-intensity interval exercise training on skeletal myopathy of chronic heart failure. Journal of Cardiac Failure, 23, 36–46. doi:10.1016/j.cardfail.2016.06.007

53.

van der Molen

Willemse

B. W.

Schokker

ten Hacken

N. H.

Postma

D. S.

Juniper

E. F.

(2003). Development, validity and responsiveness of the clinical COPD questionnaire. Health and Quality of Life Outcomes, 1, 13.

54.

Waatevik

Johannessen

Gomez Real

Aanerud

Hardie

J. A.

Bakke

P. S.

Lind Eagan

T. M.

(2016). Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD. European Respiratory Journal, 48, 82–91. doi:10.1183/13993003.00975-2015

55.

Waschki

Kirsten

A. M.

Holz

Mueller

K. C.

Schaper

Sack

A. L.

… Watz

(2015). Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 192, 295–306. doi:10.1164/rccm.201501-0081OC

56.

Watson

L. C.

Pignone

M. P.

(2003). Screening accuracy for late-life depression in primary care: A systematic review. Journal of Family Practice, 52, 956–964.

57.

Yohannes

A. M.

Raue

P. J.

Kanellopoulos

McGovern

Sirey

J. A.

Kiosses

D. N.

… Alexopoulos

G. S.

(2016). Predictors of all-cause mortality in patients with severe COPD and major depression admitted to a rehabilitation hospital. Chest, 149, 467–473.